COHLHEPP RYAN (President and COO) sold 13.7% of their position (28.75K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $833.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+18.75K
Price / share
$3.79
Trade value
$71.06K
% of position
Common Stock
Shares
−22.83K
Price / share
$28.76
Trade value
$656.65K
% of position
Common Stock
Shares
−4.31K
Price / share
$29.80
Trade value
$128.30K
% of position
Common Stock
Shares
−1.07K
Price / share
$30.35
Trade value
$32.63K
% of position
Common Stock
Shares
−536.00
Price / share
$29.00
Trade value
$15.54K
% of position
Net shares
−10K
Net value
-$762.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | M · Option Exercise | +18.75K | $3.79 | $71.06K | 9.8% | 191.64K | 210.39K |
| Common Stock Direct | 7/8/2026 | S · Sale | −22.83K | $28.76 | $656.65K | 10.9% | 210.39K | 187.56K |
| Common Stock Direct | 7/8/2026 | S · Sale | −4.31K | $29.80 | $128.30K | 2.3% | 187.56K | 183.25K |
| Common Stock Direct | 7/8/2026 | S · Sale | −1.07K | $30.35 | $32.63K | 0.6% | 183.25K | 182.18K |
| Common Stock Direct | 7/9/2026 | S · Sale | −536.00 | $29.00 | $15.54K | 0.3% | 182.18K | 181.64K |
| Total | −10K | -$762.07K | ||||||
Stock Option (Right to Buy)
Common Stock
18.75K shares
Shares
−18.75K
Strike price
3.7898
Held after
70.50K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock18.75K shares | 7/8/2026 | M · Option Exercise | −18.75K | 3.7898 | — | 70.50K |